Silencing of LCN2 represses invasion through a reduction in LCN2/MMP-9 complex formation in cholangiocarcinoma cells [20], which is linked to reduced survival of patients with cholangiocarcinoma of higher LCN2 expression [21]. The gene discussed is MMP9; the disease is cholangiocarcinoma.